Loading company details...
Beta
Latest Form 4 (Oct 19, 2026): Stephen M. R. Covey (Director): Grant/Award of 1,900 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Stephen M. R. Covey | Grant/Award | 1,900 | n/a |
| Oct 19, 2026 | Gregory K. Morris Sr. | Grant/Award | 1,900 | n/a |
| Oct 19, 2026 | Suzanne D. Snapper | Grant/Award | 1,900 | n/a |
| Oct 19, 2026 | Barry M. Smith | Grant/Award | 1,900 | n/a |
| Oct 19, 2026 | Scott E. Lamb | Grant/Award | 2,400 | n/a |
| Oct 19, 2026 | John G. Nackel | Grant/Award | 1,900 | n/a |
| Oct 19, 2026 | Christopher R. Christensen | Grant/Award | 1,900 | n/a |
| Aug 10, 2026 | Kirk Sterling Cheney, EVP, GC and Corp Secy | Sale | 1,393 | $53.7K |
| Aug 10, 2026 | Brent Guerisoli, Chief Executive Officer | Sale | 4,285 | $165.1K |
| Aug 10, 2026 | Jason Paul Steik, Chief Clinical Officer | Sale | 1,394 | $53.7K |